Grace A McComsey Selected Research

Reverse Transcriptase Inhibitors

9/2014	Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine.
11/2013	The relationship between vitamin D status and HIV-related complications in HIV-infected children and young adults.
6/2013	Metabolic complications and treatment of perinatally HIV-infected children and adolescents.
12/2012	Short communication: initiation of an abacavir-containing regimen in HIV-infected adults is associated with a smaller decrease in inflammation and endothelial activation markers compared to non-abacavir-containing regimens.
6/2009	Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovir-containing regimen.
8/2006	Oxidant stress and peripheral neuropathy during antiretroviral therapy: an AIDS clinical trials group study.
8/2004	Lack of recurrence of hyperlactatemia in HIV-infected patients switched from stavudine to abacavir or zidovudine.
5/2002	High doses of riboflavin and thiamine may help in secondary prevention of hyperlactatemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Grace A McComsey Research Topics

Disease

83	Inflammation (Inflammations) 04/2024 - 12/2008
42	HIV Infections (HIV Infection) 01/2023 - 07/2004
30	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 09/2005
24	Insulin Resistance 01/2022 - 07/2010
23	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 07/2004
17	Atherosclerosis 01/2022 - 10/2013
13	COVID-19 05/2024 - 07/2021
12	Infections 01/2023 - 06/2005
10	Vascular Diseases (Vascular Disease) 01/2023 - 04/2014
10	Vitamin D Deficiency 10/2021 - 01/2012
8	Osteoporosis 01/2018 - 03/2006
7	Weight Gain 04/2024 - 01/2020
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2017 - 11/2012
6	Metabolic Bone Diseases (Osteopenia) 07/2018 - 03/2006
6	Necrosis 01/2018 - 01/2011
5	Disease Progression 05/2024 - 10/2012
4	Hyperlactatemia 01/2005 - 05/2002
3	Hypertension (High Blood Pressure) 07/2022 - 05/2008
3	Dyslipidemias (Dyslipidemia) 01/2021 - 06/2013
3	Obesity 01/2020 - 05/2017
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 01/2014
3	Lactic Acidosis 06/2013 - 05/2002
3	Mitochondrial Diseases (Mitochondrial Disease) 06/2009 - 05/2002
2	Critical Illness (Critically Ill) 05/2024 - 11/2023
2	Rheumatoid Arthritis 01/2024 - 01/2023
2	Myocardial Infarction 01/2022 - 12/2012
2	Heart Failure 01/2021 - 01/2015
2	Fibrosis (Cirrhosis) 01/2021 - 01/2018

Drug/Important Bio-Agent (IBA)

32	Biomarkers (Surrogate Marker)IBA 05/2024 - 12/2008
21	C-Reactive ProteinIBA 01/2023 - 01/2011
20	LipidsIBA 04/2024 - 09/2003
19	Tenofovir (Viread)FDA Link 04/2024 - 01/2011
19	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2011
19	Rosuvastatin Calcium (Crestor)FDA Link 01/2019 - 02/2014
18	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 09/2007
17	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2004
16	Vitamin D FDA LinkGeneric 01/2024 - 01/2012
11	oxidized low density lipoproteinIBA 01/2023 - 04/2014
10	Emtricitabine (Emtriva)FDA Link 01/2022 - 06/2011
10	Ritonavir (Norvir)FDA Link 01/2022 - 06/2011
10	Atazanavir Sulfate (Reyataz)FDA Link 01/2022 - 06/2011
10	LDL CholesterolIBA 01/2019 - 10/2013
9	CalciumIBA 01/2022 - 04/2014
8	abacavir (Ziagen)FDA Link 01/2023 - 08/2004
8	hydroxide ionIBA 01/2022 - 01/2012
8	Lipopolysaccharide ReceptorsIBA 12/2021 - 04/2014
8	Protease Inhibitors (Protease Inhibitor)IBA 11/2016 - 01/2008
8	Reverse Transcriptase InhibitorsIBA 09/2014 - 05/2002
8	NucleosidesIBA 01/2014 - 05/2002
7	25-hydroxyvitamin DIBA 01/2022 - 01/2012
7	Raltegravir Potassium FDA Link 01/2022 - 01/2014
6	Glucose (Dextrose)FDA LinkGeneric 10/2017 - 01/2011
6	Zidovudine (Retrovir)FDA LinkGeneric 01/2017 - 08/2004
6	efavirenz (Sustiva)FDA Link 01/2017 - 08/2006
6	lamivudine drug combination abacavir FDA Link 03/2015 - 06/2011
5	CytokinesIBA 05/2024 - 10/2009
5	zonulinIBA 12/2023 - 01/2020
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2023 - 08/2009
5	fibrin fragment D (D-dimer)IBA 01/2020 - 01/2013
5	Mitochondrial DNA (mtDNA)IBA 01/2019 - 01/2011
5	Stavudine (Zerit)FDA LinkGeneric 01/2017 - 08/2004
5	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2016 - 01/2011
4	IntegrasesIBA 04/2024 - 01/2014
4	Darunavir (Prezista)FDA Link 01/2022 - 10/2014
4	AdiponectinIBA 01/2022 - 01/2019
4	Triglycerides (Triacylglycerol)IBA 01/2021 - 05/2008
4	Insulin (Novolin)FDA Link 10/2017 - 01/2011
4	Lipoproteins (Lipoprotein)IBA 01/2017 - 07/2010
3	VaccinesIBA 01/2023 - 04/2022
3	Heroin (Diamorphine)IBA 01/2023 - 10/2019
3	CreatinineIBA 09/2022 - 03/2014
3	VitaminsIBA 04/2022 - 10/2021
3	LeptinIBA 01/2022 - 01/2021
3	HLA-DR Antigens (HLA-DR)IBA 01/2021 - 04/2016
3	HDL LipoproteinsIBA 01/2021 - 01/2015
3	HDL CholesterolIBA 01/2021 - 01/2012
3	Integrase InhibitorsIBA 12/2020 - 08/2015
3	CholesterolIBA 01/2020 - 05/2008
3	LigandsIBA 01/2019 - 01/2011
3	OsteoprotegerinIBA 01/2018 - 01/2011
3	Cystatin CIBA 06/2015 - 03/2014
3	Rosiglitazone (Avandia)FDA Link 07/2012 - 03/2011
2	dolutegravirIBA 04/2024 - 01/2020
2	tenofovir alafenamideIBA 04/2024 - 11/2016
2	NucleotidesIBA 03/2024 - 09/2014
2	ProdrugsIBA 03/2024 - 01/2021
2	ZincIBA 12/2023 - 01/2020
2	AntigensIBA 01/2023 - 04/2013
2	tocilizumab (atlizumab)FDA Link 01/2023 - 01/2022
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2019
2	EnzymesIBA 01/2023 - 01/2018
2	ChemokinesIBA 12/2022 - 01/2019
2	MicronutrientsIBA 04/2022 - 01/2020
2	AdipokinesIBA 01/2022 - 05/2013
2	Matrix Gla ProteinIBA 01/2022 - 10/2021
2	Vitamin K FDA Link 01/2022 - 10/2021
2	Advanced Glycation End ProductsIBA 10/2021 - 01/2019

Therapy/Procedure

67	Therapeutics 05/2024 - 05/2002
45	Art Therapy 04/2024 - 07/2004
5	Highly Active Antiretroviral Therapy (HAART) 01/2017 - 06/2005